Mission Point Nursing: Medication Transcription Error - MI
The medication at the center of the violation was divalproex sodium, sold under the brand name Depakote. It comes in more than one form. There is a conventional delayed-release tablet, and there is an extended-release version. They are not the same thing, and they cannot simply be swapped at the same dose.
The difference matters clinically. The extended-release formulation has lower bioavailability than the conventional tablet, meaning the body absorbs it differently. Medical literature on converting patients between the two versions specifies that the extended-release daily dose needs to be 8 to 20 percent higher than the conventional dose to achieve the same effect. Doctors who prescribe one form and get the other delivered to their patient are not getting what they ordered. Neither is the patient.
Depakote is prescribed for serious conditions. It is used to treat complex partial seizures and absence seizures, sometimes as the only medication and sometimes alongside others. It is used for manic and mixed episodes in bipolar disorder. It is used to prevent migraines. In a nursing home population, where residents may have limited ability to communicate that something feels wrong, a medication error involving a drug that controls seizures is not a paperwork problem.
Inspectors rated the harm level as minimal, or potential for actual harm, and noted that few residents were affected. The violation was cited as past noncompliance, meaning the facility had already identified the problem and taken corrective steps before the survey was completed.
What the facility did after discovering the error was thorough, at least on paper. Staff went back through the records of every resident prescribed Depakote and audited each order to confirm that what was written on the medication administration record matched what the physician had actually ordered. Every resident reviewed was found to be in compliance by the time inspectors arrived. Nurses received retraining on how to transcribe medication orders. The facility also put a standing process in place: any new admission prescribed Depakote would have their order audited before it was entered into the medication record.
Inspectors reviewed the facility's monitoring documentation and concluded that corrective actions had been implemented and that compliance was being maintained.
That resolution is the official end of the story. What the inspection report does not say is how long the transcription errors had been occurring before anyone caught them, how many residents received the wrong formulation during that window, or whether any resident experienced a seizure, a mood episode, or any other consequence during the period when their medication record did not match their prescription.
The report does not say those things happened. It also does not say they didn't.
What it does say is that nurses were transcribing a medication with two non-interchangeable forms as though the distinction didn't matter, and that the facility had to go back and audit every single Depakote order after the fact to find out how widespread the problem was. An audit conducted after a violation is discovered is not the same as a system that catches errors before they reach a resident's medication cup.
Mission Point Nursing & Physical Rehabilitation Centre is a skilled nursing and rehabilitation facility in Holly, a small city in Genesee County in southeastern Michigan.
The inspection that produced this finding was a complaint survey, conducted May 27, 2026. The Depakote transcription error was the only violation documented in the four-page report.
For residents on a medication that controls seizures, the question of whether the right pill was administered on the right days is not abstract. Divalproex levels in the blood are monitored precisely because small differences in dose or formulation can shift a patient out of a therapeutic range. The facility's own corrective action acknowledged as much, committing to catch those errors at admission rather than after the fact.
Whether that commitment holds will be determined by the next inspection, or the next complaint.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Mission Point Nursing & Physical Rehabilitation Ce from 2026-05-27 including all violations, facility responses, and corrective action plans.
Additional Resources
Data source: This article is based on inspection data downloaded directly from the Centers for Medicare & Medicaid Services (CMS) via Medicare.gov. CMS releases inspection reports in bulk; we publish the findings as documented by state surveyors in the official Form CMS-2567 Statement of Deficiencies.
Plan of correction: The CMS report we receive does not include the facility's plan of correction. Facilities submit plans of correction separately to state survey agencies and those responses may not be reflected in CMS data at the time of publication. The absence of a plan of correction in our data does not mean one was not filed. Readers who want information about corrective steps taken are encouraged to contact the facility directly or their state survey agency.
Corrections may have occurred: Inspection reports reflect conditions observed on the date of the survey. Facilities may have implemented corrections, staffing changes, additional training, or other remediation since the report was issued. We report what CMS provides and encourage readers to seek current information from the facility.
Editorial process: Inspection findings are extracted from CMS source documents and synthesized using AI, reviewed for factual accuracy against the original report by our editorial team.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: August 13, 2026 · Our methodology
Mission Point Nursing & Physical Rehabilitation Ce in Holly, MI was cited for violations during a health inspection on May 27, 2026.
The medication at the center of the violation was divalproex sodium, sold under the brand name Depakote.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.